NRX Pharmaceuticals Q1 2025: Minimal Revenue, Significant Cash
Ticker: NRXPW · Form: 10-Q · Filed: May 15, 2025 · CIK: 1719406
| Field | Detail |
|---|---|
| Company | Nrx Pharmaceuticals, INC. (NRXPW) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
NRXP Q1 2025: $0 revenue, $17.1M cash. Still burning cash.
AI Summary
NRX Pharmaceuticals, Inc. filed a 10-Q for the period ending March 31, 2025. The company reported $0.001 in revenue for the quarter. As of March 31, 2025, NRX Pharmaceuticals had $17,120,120 in cash and cash equivalents, and total assets of $14,591,505.
Why It Matters
This filing provides a snapshot of NRX Pharmaceuticals' financial health at the end of Q1 2025, highlighting its revenue generation and asset base, which are crucial for investors and stakeholders.
Risk Assessment
Risk Level: medium — The company has minimal revenue and a significant cash burn, indicating a high reliance on future funding or product success.
Key Numbers
- $0.001 — Revenue (Quarterly revenue for the period ending March 31, 2025.)
- $17,120,120 — Cash and Cash Equivalents (As of March 31, 2025.)
- $14,591,505 — Total Assets (As of March 31, 2025.)
- 50,000,000 — Common Stock Authorized (As of March 31, 2025.)
Key Players & Entities
- NRX Pharmaceuticals, Inc. (company) — Filer
- Big Rock Partners Acquisition Corp. (company) — Former Company Name
- 20250331 (date) — Reporting Period End Date
- $17,120,120 (dollar_amount) — Cash and cash equivalents as of March 31, 2025
- $14,591,505 (dollar_amount) — Total assets as of March 31, 2025
FAQ
What was NRX Pharmaceuticals' revenue for the quarter ending March 31, 2025?
NRX Pharmaceuticals reported $0.001 in revenue for the quarter ending March 31, 2025.
How much cash and cash equivalents did NRX Pharmaceuticals have as of March 31, 2025?
As of March 31, 2025, NRX Pharmaceuticals had $17,120,120 in cash and cash equivalents.
What were the total assets of NRX Pharmaceuticals on March 31, 2025?
The total assets of NRX Pharmaceuticals on March 31, 2025, were $14,591,505.
What is the former name of NRX Pharmaceuticals?
The former name of NRX Pharmaceuticals was Big Rock Partners Acquisition Corp., with a name change date of October 12, 2017.
How many shares of common stock were authorized as of March 31, 2025?
As of March 31, 2025, 50,000,000 shares of common stock were authorized.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding NRX Pharmaceuticals, Inc. (NRXPW).